Picture of rolled up £5 note

Open Access research that shapes economic thinking...

Strathprints makes available scholarly Open Access content by the Fraser of Allander Institute (FAI), a leading independent economic research unit focused on the Scottish economy and based within the Department of Economics. The FAI focuses on research exploring economics and its role within sustainable growth policy, fiscal analysis, energy and climate change, labour market trends, inclusive growth and wellbeing.

The open content by FAI made available by Strathprints also includes an archive of over 40 years of papers and commentaries published in the Fraser of Allander Economic Commentary, formerly known as the Quarterly Economic Commentary. Founded in 1975, "the Commentary" is the leading publication on the Scottish economy and offers authoritative and independent analysis of the key issues of the day.

Explore Open Access research by FAI or the Department of Economics - or read papers from the Commentary archive [1975-2006] and [2007-2018]. Or explore all of Strathclyde's Open Access research...

The breath test - A call for more regional use

Heaney, A. and Kalin, R.M. and Collins, J.S.A. and Watson, R.G.P. and McFarland, R.J. (1997) The breath test - A call for more regional use. European Journal of Gastroenterology and Hepatology, 9 (7). pp. 693-696.

Full text not available in this repository. Request a copy from the Strathclyde author

Abstract

Objective: Although the C-13-urea breath test is commonly used for detection of Helicobacter pylori infection and eradication, access to commercial testing centres for analysis may at times limit its use. We have addressed this issue by establishing a regional-based means of analysis as a Hospital-University collaboration. Design/methods: A blind comparison was undertaken of C-13-urea breath test results performed 'in house' by the stable isotope laboratory in Queen's University Belfast and a commercially available C-13-urea breath test. Results: The H. pylori status of the patients (n = 110) agreed for all patients (kappa score = 1). The excess values showed good agreement. The cost of the 'in house' breath test was less than 20 pounds compared with 32.90 pounds for the commercial breath test. Conclusion: Regional access to the C-13-urea breath test could decrease costs, increase availability of testing, improve local health services and economy and increase collaborative research opportunities.